Risks and benefits of phase 1 oncology trials in the era of personalized medicine

被引：1

|

作者：

Chakiba, C. ^{[1
]}

Grellety, T. ^{[1
]}

Cousin, S. ^{[1
]}

Italiano, A. ^{[1
]}

机构：

[1] Inst Bergonie, Med Oncol, Bordeaux, France

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

10.1093/annonc/mdw387.9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1372P

引用

收藏

页数：1

相关论文

共 50 条

[41] The Era of Personalized Medicine in Oncology: Novel Biomarkers Ushering in New Approaches to Cancer Therapy
Stricker, Steve
AMERICAN HEALTH AND DRUG BENEFITS, 2011, 4 (06): : 387 - 388
[42] Comparison of adult oncology phase 1 trials to pediatric oncology phase 1 trials of targeted therapies.
Subbiah, Vivek
Kawedia, Jitesh D.
Christensen, Anthony
Hess, Kenneth R.
Patel, Kayuri
Wood, Elaine
Bitar, Ryan D.
Daw, Najat C.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[43] Exploring the Benefits and Risks of AI in Oncology
James, Ted A.
ONCOLOGY-NEW YORK, 2024, 38 (05):
[44] Evolving Paradigms of Personalized Medicine in Oncology
Dhingra, Kapil
NATIONAL MEDICAL JOURNAL OF INDIA, 2017, 30 (06): : 305 - 308
[45] Personalized medicine in oncology: next generation
Chiang, Alex
Million, Ryan P.
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (12) : 895 - 896
[46] Personalized medicine in oncology: the future is now
Richard L. Schilsky
Nature Reviews Drug Discovery, 2010, 9 : 363 - 366
[47] Personalized medicine and patient modelling in oncology
International Journal of Computer Assisted Radiology and Surgery, 2012, 7 (Suppl 1) : 239 - 248
[48] Personalized medicine in oncology by liquid biopsy
Josse, Simon
CANCER SCIENCE, 2018, 109 : 3 - 3
[49] Oncology - Personalized Medicine is already finished?
不详
BIOFUTUR, 2014, (355) : 10 - 10
[50] Personalized medicine in oncology: the future is now
Schilsky, Richard L.
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (05) : 363 - 366

← 1 2 3 4 5 →